Work

Plasmablastic multiple myeloma following clear cell renal cell carcinoma

Year: 2014

Type: article

Abstract: We aim to describe the clinicohaematological profile of an elderly male with plasmablastic multiple myeloma (MM) (IgG λ, International System Stage II) with an unfavourable outcome following chemotherapy. The serum interleukin-6 level was found to be markedly elevated (2464 pg/mL, reference; <50 pg/mL). Thirty-six months prior to MM diagnosis, he underwent left radical nephrectomy for a stage III (pT3N0M0) clear cell renal cell carcinoma (RCC, Fuhrman grade 2). The unique MM-RCC association, shared risk factors, myeloma pathobiology and clinical implications are discussed with a brief literature review.

Source: BMJ Case Reports

DOI: 10.1136/bcr-2014-204778

Authors: Somanath Padhi, Sudhagar Mokkappan, Renu G’ Boy Varghese, Ilangovan Veerappan

Institution: Pondicherry Institute of Medical Sciences

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W1985143247

FWCI: 0.424

Cites: 12

Cited by: 4

Related to: 10